345 related articles for article (PubMed ID: 34399695)
1. Protective effects of dexmedetomidine on cerebral ischemia/reperfusion injury via the microRNA-214/ROCK1/NF-κB axis.
Liu W; Shao C; Zang C; Sun J; Xu M; Wang Y
BMC Anesthesiol; 2021 Aug; 21(1):203. PubMed ID: 34399695
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine alleviates cerebral ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress dependent apoptosis through the PERK-CHOP-Caspase-11 pathway.
Liu C; Fu Q; Mu R; Wang F; Zhou C; Zhang L; Yu B; Zhang Y; Fang T; Tian F
Brain Res; 2018 Dec; 1701():246-254. PubMed ID: 30201260
[TBL] [Abstract][Full Text] [Related]
3. MiR-665 Participates in the Protective Effect of Dexmedetomidine in Ischemic Stroke by ROCK2/NF-κB Axis.
Liu Q; Wu J; Lai S; Li G
Neurochem Res; 2022 Jul; 47(7):2064-2075. PubMed ID: 35538293
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Alleviates Brain Ischemia/Reperfusion Injury by Regulating Metastasis-associated Lung Adenocarcinoma Transcript 1/MicroRNA-140-5p/ Nuclear Factor Erythroid-derived 2-like 2 Axis.
Qin Z; Xu Y
Protein Pept Lett; 2024; 31(2):116-127. PubMed ID: 38083898
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine Post-Conditioning Alleviates Cerebral Ischemia-Reperfusion Injury in Rats by Inhibiting High Mobility Group Protein B1 Group (HMGB1)/Toll-Like Receptor 4 (TLR4)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhai Y; Zhu Y; Liu J; Xie K; Yu J; Yu L; Deng H
Med Sci Monit; 2020 Jan; 26():e918617. PubMed ID: 31912804
[TBL] [Abstract][Full Text] [Related]
6. Sevoflurane prevents miR-181a-induced cerebral ischemia/reperfusion injury.
Zhang Y; Shan Z; Zhao Y; Ai Y
Chem Biol Interact; 2019 Aug; 308():332-338. PubMed ID: 31170386
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine had neuroprotective effects on hippocampal neuronal cells via targeting lncRNA SHNG16 mediated microRNA-10b-5p/BDNF axis.
Wang L; Liu W; Zhang Y; Hu Z; Guo H; Lv J; Du H
Mol Cell Biochem; 2020 Jun; 469(1-2):41-51. PubMed ID: 32323054
[TBL] [Abstract][Full Text] [Related]
8. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.
Zhu YM; Wang CC; Chen L; Qian LB; Ma LL; Yu J; Zhu MH; Wen CY; Yu LN; Yan M
Brain Res; 2013 Feb; 1494():1-8. PubMed ID: 23219579
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine preconditioning plays a neuroprotective role and suppresses TLR4/NF-κB pathways model of cerebral ischemia reperfusion.
Wang SL; Duan L; Xia B; Liu Z; Wang Y; Wang GM
Biomed Pharmacother; 2017 Sep; 93():1337-1342. PubMed ID: 28753906
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine alleviates cerebral ischemia-reperfusion injury via inhibiting autophagy through PI3K/Akt/mTOR pathway.
Li J; Wang K; Liu M; He J; Zhang H; Liu H
J Mol Histol; 2023 Jun; 54(3):173-181. PubMed ID: 37186301
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine attenuates neuronal injury induced by cerebral ischemia‑reperfusion by regulating miR‑199a.
Zhu Y; Zhao H; Zhang W; Ma X; Liu Y
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109426
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine pretreatment inhibits cerebral ischemia/reperfusion‑induced neuroinflammation via activation of AMPK.
Wang Z; Zhou W; Dong H; Ma X; He Z
Mol Med Rep; 2018 Oct; 18(4):3957-3964. PubMed ID: 30106098
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
Chen L; Cao J; Cao D; Wang M; Xiang H; Yang Y; Ying T; Cong H
Life Sci; 2019 Oct; 235():116553. PubMed ID: 31185237
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine-up-regulated microRNA-381 exerts anti-inflammatory effects in rats with cerebral ischaemic injury via the transcriptional factor IRF4.
Fang H; Li HF; Yan JY; Yang M; Zhang JP
J Cell Mol Med; 2021 Feb; 25(4):2098-2109. PubMed ID: 33314611
[TBL] [Abstract][Full Text] [Related]
15. Asiaticoside Alleviates Cerebral Ischemia-Reperfusion Injury via NOD2/Mitogen-Activated Protein Kinase (MAPK)/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhang C; Chen S; Zhang Z; Xu H; Zhang W; Xu D; Lin B; Mei Y
Med Sci Monit; 2020 Feb; 26():e920325. PubMed ID: 32006420
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats via Extracellular Signal-Regulated Kinase/Cyclic Adenosine Monophosphate Response Element Binding Protein Signaling Pathway.
Teng L; Chen W; Yin C; Zhang H; Zhao Q
World Neurosurg; 2019 Jul; 127():e624-e630. PubMed ID: 30930327
[TBL] [Abstract][Full Text] [Related]
17. Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-κB and MAPK signaling pathways in cerebral ischemia/reperfusion injury.
Xu D; Kong T; Shao Z; Liu M; Zhang R; Zhang S; Kong Q; Chen J; Cheng B; Wang C
Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166230. PubMed ID: 34358627
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine pretreatment alleviates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation through the JAK2/STAT3 pathway.
Liu H; Li J; Jiang L; He J; Zhang H; Wang K
Braz J Med Biol Res; 2022; 55():e12145. PubMed ID: 35858000
[TBL] [Abstract][Full Text] [Related]
19. Electroacupuncture Pretreatment Attenuates Cerebral Ischemia-Reperfusion Injury in Rats Through Transient Receptor Potential Vanilloid 1-Mediated Anti-apoptosis via Inhibiting NF-κB Signaling Pathway.
Long M; Wang Z; Shao L; Bi J; Chen Z; Yin N
Neuroscience; 2022 Feb; 482():100-115. PubMed ID: 34929338
[TBL] [Abstract][Full Text] [Related]
20. Ligustilide ameliorates hippocampal neuronal injury after cerebral ischemia reperfusion through activating PINK1/Parkin-dependent mitophagy.
Mao Z; Tian L; Liu J; Wu Q; Wang N; Wang G; Wang Y; Seto S
Phytomedicine; 2022 Jul; 101():154111. PubMed ID: 35512628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
